20 May 2013
Keywords: teva, enters, drug, alliance, ucb, usa, specialty
Article | 21 January 2008
Teva Specialty Pharmaceuticals, the US respiratory therapy unit of Israeli generics giant Teva Pharmaceutical Industries, has agreed to
co-commercialize its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 January 2008
28 January 2008
14 January 2008
© 2013 thepharmaletter.com